Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 May-Jun;26(3):87-93.
doi: 10.1038/ijir.2013.41. Epub 2013 Dec 5.

Reasons and predictive factors for discontinuation of PDE-5 inhibitors despite successful intercourse in erectile dysfunction patients

S-C Kim  1 , Y-S Lee  2 , K-K Seo  3 , G-W Jung  4 , T-H Kim  5
Affiliations
Free PMC article

Reasons and predictive factors for discontinuation of PDE-5 inhibitors despite successful intercourse in erectile dysfunction patients

S-C Kim et al. Int J Impot Res. 2014 May-Jun.
Free PMC article

Abstract

This study was aimed to identify characteristics of ED patients who discontinued PDE5i despite successful intercourse. Data were collected using a questionnaire from 34 urologic clinics regardless of the effect (success or failure) of PDE5i treatment by visiting the clinics (717), e-mail (64) or post (101) for 882 ED patients who had previously taken any kind of PDE5i on demand four or more times. Discontinuation of PDE5i was defined if the patient had never taken PDE5i for the previous 1 year despite successful intercourse. Of the 882 patients, 485 were included in the final analysis. Difference in the socio-demographic, ED- and partner-related data between the continuation and discontinuation group and factors influencing discontinuation of the PDE5i were analyzed. Among 485 respondents (mean age, 53.6), 116 (23.9%) had discontinued PDE5i use despite successful intercourse. Most common reasons for the discontinuation were 'reluctant medication-dependent intercourse' (31.0%), 'spontaneous recovery of erectile function without further treatment' (30.2%), and 'high cost' (26.7%). In multiple logistic regression analysis, independent factors influencing discontinuation of the drug were cause of ED (psychogenic), short duration of ED, low education (⩽ middle school), and religion (Catholic). In partner-related compliance, only partner's religion (Catholic) was a significant factor.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The process of patient recruitment. ED, erectile dysfunction; PDE5i, phosphodiesterase type 5 inhibitor.
See this image and copyright information in PMC

References

    1. Balkrishnan R. Predictors of medication adherence in the elderly. Clin Therapeut. 1988;20:764–771. - PubMed
    1. Porst H.Oral pharmacotherapy of erectile dysfunctionIn: Porst H, Buvat J. the Standards Committee of the International Society for Sexual Medicine eds. Standard Practice in Sexual Medicine Blackwell Publishing: Oxford; 75–93.2006
    1. Gresser U, Gleiter CH. Erectile dysfunction: comparison of efficacy and side effects of the PDE-5 inhibitors sildenafil, vardenafil and tadalafil—review of the literature. Eur J Med Res. 2002;7:435–446. - PubMed
    1. Klotz T, Mathers M, Klotz R, Sommer F. Why do patients with erectile dysfunction abandon effective therapy with sildenafil (Viagra) Int J Impot Res. 2005;17:2–4. - PubMed
    1. Jiann BP, Yu CC, Su CC, Tsai JY. Compliance of sildenafil treatment for erectile dysfunction and factors affecting it. Int J Impot Res. 2006;18:146–149. - PubMed

Publication types

Substances